Live Breaking News & Updates on Hepzato Kit|Page 4

Stay updated with breaking news from Hepzato kit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Melanoma Research Alliance Statement on FDA Approval of Hepzato Kit for Patients with Uveal Melanoma with Liver Metastases

/PRNewswire/ The Melanoma Research Alliance (MRA) released the following statements from MRA Chief Science Officer Joan Levy, PhD and MRA Chief Executive. ....

United States , Leon Black , Marc Hurlbert , Melanoma Research Alliance , Food Drug Administration , Science Officer Joan Levy , Executive Officer Marc Hurlbert , Drug Administration , Hepzato Kit ,

Delcath Systems Appoints Vojislav Vukovic as Chief Medical Officer

/PRNewswire/ Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and. ....

United States , Federation Of Bosnia And Herzegovina , Bosnia Herzegovina , Ben Shamsian , Vojislav Vojo Vukovic , Gerard Michel , American Society Of Clinical Oncology , Taiho Oncology Inc , Delcath Systems Inc , American Society Of Hematology , Prnewswire Delcath Systems Inc , Drug Administration , Synta Pharmaceuticals Inc , University Of Sarajevo , Company Or Delcath , University Of Toronto , European Society For Medical Oncology , American Association For Cancer Research , Chief Medical Officer , Senior Vice President , Aileron Therapeutics , Synta Pharmaceuticals , Radiation Biology , Tumor Biology , American Association , Cancer Research ,

Delcath Systems Provides Business Update and Reports Preliminary First Quarter 2023 Financial Results

Delcath Systems Provides Business Update and Reports Preliminary First Quarter 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Gerard Michel , Ben Shamsian , Johnr Sylvester , Stonepine Capital Management , Serrado Capital , Prnewswire Delcath Systems Inc , Delcath Systems Inc , Venture Opportunities Fund , Drug Administration , Exchange Commission , Hepzato Kit , Hepatic Delivery System , Prescription Drug User Fee Act , Vivo Capital , Logos Capital , Rosalind Advisors , Avenue Venture Opportunities Fund , Journal Cardiovascular , Chief Executive Officer , First Quarter , Quarterly Report , Toll Free , Access Code , Delcath Systems , United States Food ,

Delcath Systems, Inc. Announces FDA Acceptance of New Drug Application Resubmission of Hepzato Kit with a PDUFA Date of August 14, 2023

NEW YORK, March 27, 2023 /PRNewswire/ Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced that the US. | March 27, 2023 ....

United States , Ben Shamsian , Gerard Michel , Prnewswire Delcath Systems Inc , Delcath Systems Inc , Exchange Commission , Drug Administration , Delcath Systems , Hepatic Delivery System , Chief Executive , Hepzato Kit , United States Food , Delivery System , Private Securities Litigation Reform Act , Relations Contact , Nc Stock Exchange , Press Release , He Dcth Us24661p8077 ,

Delcath Systems Gets FDA Acceptance of NDA Resubmission of Hepzato Kit

By Chris Wack

Delcath Systems Inc. said Monday that the U.S. Food and Drug Administration has accepted its new drug application resubmission for the Hepzato Kit, a melphalan hydrochloride for. | March 27, 2023 ....

Chris Wack , Delcath Systems Inc , Drug Administration , Hepzato Kit , Dow Jones , Delcath Systems , Nc Stock Exchange , Press Release , Ydrochloride Dcth Us24661p8077 ,